Advanced HIV still leads to critical illness — and ICU stays. We break down the latest data published in @IDSAInfo @CIDJournal and what it means for frontline care: #HIVCare #CriticalCare #AdvancedHIV

Published in @CIDJournal: Just 11% of people with HIV at a @parkland clinic had documented or presumptive measles immunity. Clinicians: Are we missing key vaccination opportunities? . 🔗:

Blazing-fast image creation – using just your voice. Try Grok Imagine.

New meta-analysis confirms: ART before conception nearly eliminates vertical HIV transmission — even during breastfeeding. Clinicians: Early ART and viral suppression remain key.

Did you know azithromycin is no longer the CDC’s 1st choice for chlamydia or gonorrhea, but still the most prescribed? @stanfordmed's Shiying Hao, PhD, & Neil Kamdar, MA, explain why prescribing habits lag behind guidelines & what it means for resistance:

Weight gain on HIV meds isn’t just about the drugs. A new @iasociety 2025 study explores the factors behind it — and what clinicians should watch for: #IAS2025 #HIVCare #ART

Twice-yearly injectable PrEP is here. In an interview with @BodyPROHIV, @JncherabieMD shares firsthand insights on dosing, nodules, and what patients should expect with lenacapavir:

How people navigate HIV prevention in an era of multiple protective strategies: #HIV

REPRIEVE trial shows pitavastatin cuts major CV events by 35% in people with HIV. New guidelines recommend statins for those with ≥5% ASCVD risk. What to know: . #HIV #HeartHealth #Statins #Prevention

Real-world study published in @CIDJournal: 92% of patients with viremia achieved suppression after starting long-acting ART. Expert analysis from Benjamin Young, MD, PhD: #HIVResearch

At @iasociety 2025, Dr. Ricky Hsu shares real-world insights on CAB/RPV long-acting ART — and what it means for patients with viremia. 🔗: . #HIV #LongActingART #IAS2025 #Oncology #InfectiousDiseases

Geriatric syndromes hit earlier and harder for people aging with HIV. Dr. Alice Zhabokritsky breaks down her recently @ncbi published review — and how providers can respond. Our @BodyPROHIV interview: #GeriatricMedicine

Providers know PrEP. But are they comfortable prescribing it to youth? A Maryland study reveals: not always. 🩺 How to bridge the gap with training, tools, and trust:

CDC staff say critical work addressing trauma in HIV care is in limbo — stalled by budget cuts, layoffs, and leadership changes. The recent workplace shooting only deepened existing instability. 🔗 Full story:

U.S. transgender women report positive experiences with both oral and injectable HIV pre-exposure prophylaxis (PrEP) but choice is crucial, according to new data from #IAS2025:

Could over-the-counter PrEP be the next frontier in HIV prevention? Epidemiologist Julia Marcus, PhD, MPH, makes the case for expanding access by removing prescription and lab barriers — especially for underserved communities:

🧬 Aging and HIV: Could understanding one help cure the other? Dr. Alan Landay dives deep into how “inflammaging” and senescent cells shape HIV cure strategies: #CROI2025 #HIVResearch

Housing insecurity is common among people with HIV and it’s a major barrier to care and prevention. A new @TheLancetHIV review calls housing a core issue in ending the epidemic: #HIV #MedTwitter

Published in @CIDJournal: 2-year study comparing CAB-LA vs. FTC/TDF PrEP found small but meaningful differences in bone density impact, offering a fresh lens on how we counsel patients about PrEP and long-term bone health: #HIV #PrEP #BoneHealth

When people with #HIV have access to nutritious food, outcomes improve. A Bay Area program offering meals, groceries & support led to better ART adherence & fewer hospitalizations. Why Benjamin Young, MD., PhD, calls it a "landmark" study: . #HealthEquity

Recent study published in @CIDJournal: Men over 40 with HIV face 2x the risk of coronary atherosclerosis and 3x the risk of obstructive plaque compared to peers without HIV, even with well-controlled virus. #HIV #HeartHealth #Atherosclerosis #CardioCare